Wednesday, Dec 11 2024 | Time 03:15 Hrs(IST)
image
Business EconomyPosted at: Nov 8 2024 6:12PM


Granules India receives EIR from US FDA for Unit V Facility

Hyderabad, Nov 8 (UNI) Granules India Limited, a leading pharmaceutical manufacturing company, on Friday announced it has received an Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration (FDA) for its Unit V facility located at Jawaharlal Nehru Pharma City (JNPC), in Anakapalli district of Andhra Pradesh.
The inspection was conducted by the US FDA from April 8 to April 12, 2024, the Pharma company said in a release here.
The US FDA inspection classified the facility as "No Action Indicated" (NAI), indicating compliance with current Good Manufacturing Practices (cGMP) standards and confirming that no further regulatory action is required.
This outcome reflects the facility's high standards in the production of Active Pharmaceutical Ingredients (APIs) and Finished Dosages (FDs) for both oncology and non-oncology therapeutic areas.
During the inspection, the FDA conducted a comprehensive Pre-Approval Inspection (PAI) and cGMP audit, which concluded with zero Form 483 observations, underscoring Granules India’s commitment to stringent quality control, regulatory compliance, and operational excellence.
"The successful completion of this US FDA inspection with zero observations and the subsequent receipt of the EIR with NAI status reflects our unwavering commitment to maintaining the highest quality standards in our manufacturing operations," said Dr. Krishna Prasad Chigurupati, Chairman & Managing Director.
Granules India’s Unit V facility plays a pivotal role in the company’s mission to deliver high-quality and accessible pharmaceuticals globally by prioritizing regulatory compliance, operational excellence, and value delivery to stakeholders.
The company remains dedicated to producing top-quality pharmaceutical products that meet global health standards.
UNI KNR CS1811
Please log in to get detailed story.
Tags: #Granules India receives EIR from US FDA for Unit V Facility
More News

Kottayam-Kochi rubber market rates

10 Dec 2024 | 9:06 PM

Kottayam Dec 10(UNI) Following were the Rubber Market rates announced by the Rubber Board here on Tuesday per quintal.

see more..

WhatsApp kicks off Bharat Yatra to train small businesses across India

10 Dec 2024 | 8:42 PM

New Delhi, Dec 10 (UNI) In a first-of-its-kind, mobile digital app WhatsApp has started a “unique” WhatsApp Bharat Yatra, an initiative aimed at providing on-ground, in-person training to small businesses across India to help small businesses fully leverage the capabilities of WhatsApp, enhancing their digital skills and business growth potential.

see more..
Consumption of stainless steel in India grows 11 percent over FY23: ISSDA

Consumption of stainless steel in India grows 11 percent over FY23: ISSDA

10 Dec 2024 | 8:31 PM

New Delhi, Dec 10 (UNI) India’s per capita consumption of stainless steel has increased to 3.1 kilogram in 2023-24 from 2.25 kgs five years ago that is in 2018-19, even as the industry continues to grapple with challenges posed by the persistent dumping of substandard stainless steel, particularly from China, adversely impacting domestic manufacturers.

see more..

Bharat Forge raises Rs 1,650 crore for debt repayment, growth initiatives

10 Dec 2024 | 8:23 PM

New Delhi, Dec 10 (UNI) Bharat Forge Limited has raised Rs 1,650 Crores with the closure of its qualified Institutional Placement (QIP). The issue witnessed significant interest across Domestic and Foreign Qualified Institutional investors resulting in more than 10X demand of the issue size.

see more..

Varcas-Ryoto Electrix targets to set up 25,000 EV charging stations in Telangana

10 Dec 2024 | 8:07 PM

Hyderabad, Dec 10(UNI) Varcas-Ryoto Electrix , an eco-friendly mobility solutions and EV scooters manufacturer, on Tuesday announced to set up 25,000 EV charging stations for two-wheelers and three-wheelers in Hyderabad in the next year.

see more..
image